The statement further said that the alliance is working closely with the International generic and biosimilar medicines association, the WHO, the Association of Affordable Medicines in the US, Medicines for Europe, and several other country associations to understand any potential impact on supply of medicines globally.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Up3SNj
via IFTTT
0 comments:
Post a Comment